A new study published in JAMA Psychiatry suggests that Ozempic and similar semaglutide-based drugs may significantly reduce physical health risks for people with schizophrenia. The medication improved blood sugar levels and reduced weight gain—two major problems linked to antipsychotic treatments.
10 Dec 2025-09:40
10 Dec 2025-09:40
